The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Genome-Informed Targeted Therapy for Osteosarcoma
Open accessAbstract
Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially unchanged for more than 30 years. Osteosarcoma is characterized by widespread and recurrent somatic copy-number alterations (SCNA) and structural rearrangements. In contrast, few recurrent point mutations in protein-coding genes have been identified, suggesting that genes within SCNAs are key oncogenic drivers in this disease. SCNAs and structural rearrangements are highly heterogeneous across osteosarcoma cases, suggesting the need for a genome-informed approach to targeted therapy. To identify patient-specific candidate drivers, we used a simple heuristic based on degree and rank order of copy-number amplification (identified by whole-genome sequencing) and changes in gene expression as identified by RNA sequencing. Using patient-derived tumor xenografts, we demonstrate that targeting of patient-specific SCNAs leads to significant decrease in tumor burden, providing a road map for genome-informed treatment of osteosarcoma. Significance: Osteosarcoma is treated with a chemotherapy regimen established 30 years ago. Although osteosarcoma is genomically complex, we hypothesized that tumor-specific dependencies could be identified within SCNAs. Using patient-derived tumor xenografts, we found a high degree of response for “genome-matched” therapies, demonstrating the utility of a targeted genome-informed approach. This article is highlighted in the In This Issue feature, p. 1
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the paitients with metastatic disease either at diagnosis or at the time of recurrence portends a dismal prognosis with 5-year survival of only 20-30% [8].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredIn the citing paper
“This genomic complexity has long been interpreted as a sign of chromosomal instability but emerging data suggest that the mechanisms triggering complexity are active early in the process of malignant transformation 35,37 .”
From Osteosarcoma (2022) · cites this paper as [35]
In the citing paper
“These rearrangements give rise to genome-wide copy number alterations, usually dominated by copy number loss, including of PTEN and CDKN2A/B, but with recurrent amplifications of MYC, VEGFA and CCNE1 (ref.35 ).”
From Osteosarcoma (2022) · cites this paper as [35]
In the citing paper
“Of note, the resulting complex genomes are subsequently maintained with some fidelity, even from diagnosis to relapse 35,37 .”
From Osteosarcoma (2022) · cites this paper as [35]
In the citing paper
“Copy number amplifications of potentially targetable genes seemed to predict sensitivity to specific agents 35 ; however, subsequent work has shown that the picture is much more complicated 9 .”
From Osteosarcoma (2022) · cites this paper as [35]
In the citing paper
“Recurrent CDK4 alterations have been described in osteosarcoma 35 .”
From Osteosarcoma (2022) · cites this paper as [35]
In the citing paper
“Furthermore, current molecular research continues to classify osteosarcomas not by histological appearance via classical osteosarcoma pathological descriptions but by proteo-genomic drivers of disease that provide further insight into disease biology and may have both prognostic and therapeutic implications 35 .”
From Osteosarcoma (2022) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Aligning sequence reads, clone sequences and assembly contigs with BWA-MEMPreprint
Li, H. (2013) · arXiv (Cornell University) · doi:10.48550/arxiv.1303.3997 · Cited by 10,154
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Aligning sequence reads, clone sequences and assembly con*gs with BWA-MEMPreprint
Li, H. (2014) · arXiv (Cornell University) · doi:10.6084/m9.figshare.963153.v1 · Cited by 5,155
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,926
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Rausch, T., Zichner, T., Schlattl, A., Stütz, A. M., Beneš, V., & Korbel, J. O. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts378 · Cited by 2,438
Flagged first, then by citations
1 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 457
Genomic analysis of radiation-induced osteosarcoma in the maxilla
Yokoyama, Y., Ueki, Y., Ohshima, S., Omata, J., Takahashi, T., Shodo, R., Yamazaki, K., & Horii, A. (2023) · Oral Oncology Reports · doi:10.1016/j.oor.2023.100107 · Cited by 2
Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma
Rademacher, M. J., Faber, M. L., Bone, K. M., Medin, J. A., & Schloemer, N. J. (2024) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2024.104898 · Cited by 2
Wu, C.-C., Huang, L., Zhang, Z., Ju, Z., Song, X., Kolb, E. A., Zhang, W., Gill, J. B., Ha, M. J., Smith, M. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69382-8 · Cited by 3
Fei, X., Li, Z., Pan, Z., Liang, Y., Tan, C., Cheng, D., & Yang, Q. (2024) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-024-04695-z · Cited by 2
Bojic, L., Perić, M., Karanović, J., Milošević, E., Kovačević‐Grujičić, N., & Milivojević, M. (2025) · Cancers · doi:10.3390/cancers17101677 · Cited by 2
Yehya, A. H. S., Al‐Mansoub, M. A., Al‐Suede, F. S. R., Sultan, S. B. S. H., Abduraman, M. A., Amanina, A. N., Alrawashdeh, M., Jafari, S. F., & Majid, A. M. S. A. (2022) · Journal of Angiotherapy · doi:10.25163/angiotherapy.624302 · Cited by 2
Wang, X., Gan, L., Ju, Y., Tang, M., & Liu, W. (2021) · Journal of Immunology Research · doi:10.1155/2021/9989321 · Cited by 2
Zhang, C. Q., Yang, S., Zhang, L. J., nan, J., & Chen, D. Q. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/5417753 · Cited by 2
RetractedKamolphiwong, R., Kanokwiroon, K., Wongrin, W., Chaiyawat, P., Klangjorhor, J., Settakorn, J., Teeyakasem, P., Sangphukieo, A., & Pruksakorn, D. (2022) · Gene · doi:10.1016/j.gene.2022.147106 · Cited by 2
Unveiling the prognostic implications of RPLP1 upregulation in osteosarcoma.
Du, X., Wei, H., Zhang, B., Pang, L. K., Zhao, R., Zhang, X. D., & Yao, W. (2023) · PubMed Central · Cited by 2
Molecular pathology of osteosarcoma
Fei, F., Harada, S., Wei, S., & Siegal, G. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00029-3 · Cited by 3
STING activation reshapes the tumor microenvironment leading to tumor regression in osteosarcomaPreprint
Young, E. P., Johnson, C. A., Lee, A. G., Morris, D., Tsui, J. L., Breese, M. R., Cámara, J. A., Schott, C. R., Abram, C. L., Leung, S. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684275 · Cited by 2
Self-citationCancer stem cells and clonal evolution in bone sarcomas
Rodríguez, R., Hatina, J., Gambera, S., Menéndez, S. T., & García-Castro, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00010-4 · Cited by 1
Umeda, K., Sakamoto, A., Noguchi, T., Uchihara, Y., Kobushi, H., Akazawa, R., Ogata, H., Saida, S., Kato, I., Hiramatsu, H., et al. (2022) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002521 · Cited by 1
Transforming osteosarcoma care: from historical milestones to precision medicine advances
Wang, J., Geller, D. S., Sun, L., & Tang, X. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.11.027 · Cited by 1
Wang, Y., Yuan, J., Guo, K., Zhang, Z., Zhu, J., Arya, S., Huang, G., Li, S., Chen, Q., Liu, X., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1517971 · Cited by 1
NFATC3 enhances osteosarcoma progression by increasing PD-L1 and CXCL2 levels
Liang, F., Tang, B., Chen, C., Meng, G., Huang, N., Xiang, J., Jian, H., Huang, Z., & Cheng, J. (2025) · Medical Oncology · doi:10.1007/s12032-025-02850-x · Cited by 1
Romanko, Y. S., & Reshetov, I. V. (2025) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2025-24-3-162-171 · Cited by 1
Chen, J., Situ, Y., Cai, J., Liao, W., Jiang, D., Huang, C., Zheng, J., Peng, L., & Lin, H. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s569823 · Cited by 1
Ferrena, A., Zhang, R., Wang, J., Zheng, X. Y., Göker, B., Barotti, G., Borjihan, H., Chae, S., Lo, Y., Zhao, H., et al. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0294 · Cited by 2
ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2
Zou, Y., Zhong, J., Huo, L., Chen, J., Yu, X., Wang, J., Chen, Z., Yin, L., Zeng, C., Zhang, X., et al. (2026) · Cell Discovery · doi:10.1038/s41421-026-00890-9 · Cited by 1
IGF2R-Targeted Alpha Therapy of Osteosarcoma Enabled by Conjugated [ 225 Ac]Ac-Macropa-PEG 4 -IF3
Shah, S. Q., Santos‐Oliveira, R., İlem‐Özdemir, D., & Shabnam, M. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00125 · Cited by 1
Masuda, T., Tatsumi, Y., Watanabe, T., & Kamikubo, Y. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108275 · Cited by 1
Vijayakumar, S., Lewis, S., Matrana, M. R., Vasquez, R., Singh, A., Duesbery, N. S., Collier, A. B., Larned, Z., Barr, J., Orr, W. R., et al. (2026) · Current Oncology · doi:10.3390/curroncol33060342 · Cited by 1
Zheng, Z. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108294 · Cited by 1
Understanding and Overcoming Osteosarcoma Heterogeneity
Cho, S., Shelmidine, K., & Yustein, J. T. (2026) · Biomolecules · doi:10.3390/biom16060874 · Cited by 1
Self-citationSaito, M., Nakasuka, F., Sankoda, N., Wang, Y., Taguchi, J., Ohta, S., Yamada, Y., Ozawa, M., Sakurai, S., Kondo, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74929-6 · Cited by 1
Paediatric therapeutic development workshop on osteosarcoma
Baxter, J. S., Montiel-Equihua, C., Molenaar, J. J., Berlanga, P., Bishop, M. W., Blanc, P., Campbell-Hewson, Q., Casanova, M., Cortés‐Ciriano, I., Crompton, B. D., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03572-1 · Cited by 1
Experimental Study of Somatic Variants of Osteosarcoma by Whole-Exome Sequencing
Hou, J., Liu, G., Zhang, P., Wang, B., Yan, Q., Pin, W., Wang, C., & Yao, W. (2020) · Medical Science Monitor · doi:10.12659/msm.920826 · Cited by 1
Cheng, S., & Wang, W. (2022) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-022-01319-5 · Cited by 1
Zhang, Y., Wei, J., Kong, L., Song, M., Zhang, Y., Xiao, X., Cao, H., Li, Z., Yang, N., & Jin, Y. (2023) · Aging · doi:10.18632/aging.204786 · Cited by 1
Hu, J., Yang, X., Ren, J., Zhong, S., Fan, Q., & Li, W. (2023) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2023.2240879 · Cited by 1
A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis
Wang, Y., Ming, G.-F., & Bohua, G. A. O. (2023) · Acta Orthopaedica Belgica · doi:10.52628/89.2.10491 · Cited by 1
Yu, R., Lü, G., Cheng, B., Li, J., Jiang, Q., & Lan, X. (2023) · Journal of Orthopaedic Research® · doi:10.1002/jor.25757 · Cited by 1
Silver, K. I., Mannheimer, J., Saba, C., Hendricks, W. P. D., Wang, G., Day, K. R., Warrier, M., Beck, J. A., Mazcko, C. N., & LeBlanc, A. K. (2024) · Veterinary oncology. · doi:10.1186/s44356-024-00004-1 · Cited by 2
Wang, K., Shi, C., Liu, L., Yan, H., Wang, D., Ding, M., Tong, J., He, Y., Hu, Y., Chen, C., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117279 · Cited by 1
Jin, Q., Zhou, T., Yao, Y., Yu, H.-Q., Che, H.-B., Zhang, M., Cui, C., Wang, Y., Li, C., Xing, L., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111539 · Cited by 1
Li, S., Wang, T., Wang, E., Lin, L., & Zhong, W. (2025) · Physiology International · doi:10.1556/2060.2025.00551 · Cited by 1
Zhang, S., Chen, H., Liu, W., Fang, L., Qian, Z., Kong, R., Zhang, Q., Li, J., & Cao, X. (2020) · Research Square · doi:10.21203/rs.3.rs-61546/v1 · Cited by 1
Ji, T., Shi, Q., Mei, S., Liang, H., Xie, L., Ren, T., Sun, K., Li, D., Tang, X., Zhang, P., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1722972/v1 · Cited by 1
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaPreprint
Kinnaman, M. D., Zaccaria, S., Makohon-Moore, A. P., Arnold, B., Levine, M. F., Gundem, G., Ossa, J. A., Głodzik, D., Rodriguez-Sanchez, I., Bouvier, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.05.522765 · Cited by 1
Fordham, A. M., Brown, L. M., Mayoh, C., Salib, A., Barger, Z. A., Wong, M., Sian, T. C. C. L. K., Xie, J., Gunther, K., Trebilcock, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.548825 · Cited by 1
Ferrena, A., Zhang, R., Wang, J., Zheng, X. Y., Göker, B., Borjihan, H., Chae, S., Lo, Y., Zhao, H., Schwartz, E. L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.04.597347 · Cited by 1
Lietz, C. E., Newman, E. T., Kelly, A. D., Xiang, D. H., Zhang, Z., Ramavenkat, N., Bowers, J. J., Lozano‐Calderón, S. A., Ebb, D. H., Raskin, K. A., et al. (2024) · medRxiv · doi:10.1101/2024.06.19.24309087 · Cited by 1
Seiden, E. E., Richardson, S. M., Everitt, L. A., Knafler, G. J., Kinsella, G. P., Walker, A. L., Whiteside, V. A., Buschbach, J. D., Gandhi, D. A., Saadatzadeh, M. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.22.654354 · Cited by 1
Yilmaz, F., Kong, W., Syed, S. A., O’Neill, F. H., Lombardi, J. T., Ng, P. K. S., Lau, C. C., & Lee, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.697157 · Cited by 1
Smith, G. A., van Belzen, I. A. E. M., Epinette, M., Herdes, E., Mercer, K. L., Butterworth, C. G., Rust, A. G., Flanagan, A. M., Jones, M. G., Cortés‐Ciriano, I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.27.721100 · Cited by 1
Functional Validation Of Candidate Osteosarcoma Genes Identified Via Sleeping Beauty Mutagenesis
Smeester, B. A. (2020) · University of Minnesota Digital Conservancy (University of Minnesota)
Chu, S. (2019) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/79560
Risk score model of autophagy-related genes in osteosarcomaPreprint
Qin, W., Jiang, M., Hu, Y., Xie, M., Jike, Y., & Bo, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-936589/v1
Mammalian models of bone sarcomas
Muñoz-García, J., Lézot, F., Cochonneau, D., Grigoriadis, A. E., & Heymann, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00013-x
Colletti, M., & Cruz, M. (2010)
Genomic and proteomic profiling of osteosarcoma
Patiño‐García, A., & Lecanda, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00054-2
Descriptive epidemiology of soft tissue and bone sarcomas in Lebanon
Zerdan, M. B., Meouchy, P., Halim, N. A., Saghieh, S., Sbaity, E., Haidar, R., Abbas, J., Ibrahim, A. M. H., Khalifeh, M., & Assi, H. I. (2022) · Journal of International Medical Research · doi:10.1177/03000605221082852
Gaspar, N. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736286746.793579340
Sensitive multimodal profiling of native DNA by transposase-mediated single-molecule sequencingPreprint
Nanda, A. S., Wu, K., Kasinathan, S., Ostrowski, M. S., Clugston, A. S., Satpathy, A. T., Sweet-Cordero, A., Goodarzi, H., & Ramani, V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.07.502893
Distinct Genomic Features Between Osteosarcomas Firstly Metastasing to Bone and to LungPreprint
Xie, L., Cai, Z., Lu, H., Meng, F., Zhang, X., Luo, K., Su, X., Yan, L., Xu, J., Lou, J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1354631/v1
Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma
Weiser, D. A., Hayashi, M., & Applebaum, M. A. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0390
Tian, J., Chen, C., Rao, M., Zhang, M., Lu, Z., Cai, Y., Ying, P., Li, B., Wang, H., Wang, L., et al. (2023) · doi:10.1158/0008-5472.c.6513904.v1
LeBlanc, A. K., Mazcko, C. N., Cherukuri, A., Berger, E. P., Kisseberth, W. C., Brown, M. E., Lana, S. E., Weishaar, K. M., Flesner, B. K., Bryan, J. N., et al. (2023) · doi:10.1158/1078-0432.c.6529898
Cillo, A. R., Mukherjee, E., Bailey, N. G., Onkar, S., Daley, J. D., Salgado, C. M., Li, X., Liu, D., Ranganathan, S., Burgess, M. A., et al. (2023) · doi:10.1158/1078-0432.c.6532980
Cillo, A. R., Mukherjee, E., Bailey, N. G., Onkar, S., Daley, J. D., Salgado, C. M., Li, X., Liu, D., Ranganathan, S., Burgess, M. A., et al. (2023) · doi:10.1158/1078-0432.c.6532980.v1
LeBlanc, A. K., Mazcko, C. N., Cherukuri, A., Berger, E. P., Kisseberth, W. C., Brown, M. E., Lana, S. E., Weishaar, K. M., Flesner, B. K., Bryan, J. N., et al. (2023) · doi:10.1158/1078-0432.c.6529898.v1
Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Slotkin, E. K., Bowman, A. S., Levine, M. F., Cruz, F. S. D., Coutinho, D. F., Sanchez, G. D. I., Rosales, N., Modak, S. I., Tap, W. D., Gounder, M. M., et al. (2023) · doi:10.1158/1541-7786.22525980
Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Slotkin, E. K., Bowman, A. S., Levine, M. F., Cruz, F. S. D., Coutinho, D. F., Sanchez, G. D. I., Rosales, N., Modak, S. I., Tap, W. D., Gounder, M. M., et al. (2023) · doi:10.1158/1541-7786.22525980.v1
Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Slotkin, E. K., Bowman, A. S., Levine, M. F., Cruz, F. S. D., Coutinho, D. F., Sanchez, G. D. I., Rosales, N., Modak, S. I., Tap, W. D., Gounder, M. M., et al. (2023) · doi:10.1158/1541-7786.c.6544977.v1
Rajan, S., Zaccaria, S., Cannon, M. V., Cam, M., Gross, A. C., Raphael, B. J., & Roberts, R. D. (2023) · doi:10.1158/2767-9764.c.6551261
Xia, M., Tong, S., & Gao, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2834333/v1
Kusanishi, T., Tanaka, N., Itoi, M., 井尻, 美., Ebisawa, K., Suzuka, K., Hagiwara, Y., Yonemoto, T., Araki, A., & Itami, M. (2023) · International Cancer Conference Journal · doi:10.1007/s13691-023-00613-x
CONTROLE DE QUALIDADE E SEGURANÇA
da Silva, M. V., & Müller, R. (2023) · doi:10.22533/at.ed.82423100813
Falcone, C., Campbell, D. C. D. P., da Silva, K. S. M., & de Lima, M. R. (2023) · doi:10.22533/at.ed.8242310082
EUTANÁSIA PARA ROEDORES E LAGOMORFOS
Pinto, M. S. F. (2023) · doi:10.22533/at.ed.82423100814
PRODUÇÃO DE ANTICORPOS POLICLONAIS
dos Santos, I. B. (2023) · doi:10.22533/at.ed.8242310088
AVALIAÇÃO E INTERVENÇÃO CLÍNICA EM MODELO MURINO
de Lima, M. R. (2023) · doi:10.22533/at.ed.8242310084
FINALIZAÇÃO HUMANITÁRIA: LEGISLAÇÃO BRASILEIRA E A IMPORTÂNCIA DO ENSINO
Rossi, M. I. D., & Abbagliato, A. S. (2023) · doi:10.22533/at.ed.8242310083
CIRURGIAS EXPERIMENTAIS E PONTO FINAL HUMANITÁRIO EM BIOMODELOS ANIMAIS
Ribeiro, W. L. C., de Almeida, C. A. S., & Oliveira, A. C. A. (2023) · doi:10.22533/at.ed.8242310089
CONCEITOS GERAIS EM CIÊNCIA EM ANIMAIS DE LABORATÓRIO E FINALIZAÇÃO HUMANITÁRIA
Campbell, D. C. D. P. (2023) · doi:10.22533/at.ed.8242310081
da Silva, J. D. P. A., de Lima, M. R., & Campbell, D. C. D. P. (2023) · doi:10.22533/at.ed.82423100812
Zhang, Y., Lu, G., Guan, Y., Xu, T., Duan, Z., & Li, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24990 · Cited by 1
Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2024) · doi:10.1158/1078-0432.c.7077821.v1
Self-citationSchott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2024) · doi:10.1158/1078-0432.c.7077821
Self-citationJacobs, J. E., Davis, L. E., & McWeeney, S. K. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1303404
CuPCA: a web server for pan-cancer association analysis of large-scale cuproptosis-related genes
Xu, Y., Ma, Z., Wang, Y., Zhang, L., Ye, J., Chen, Y., & Yuan, Z. (2024) · Database · doi:10.1093/database/baae075
Pharmacogenomics in Pediatric Oncology Research and Treatment
Kager, L., & Evans, W. E. (2024) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-29.5.554
Targeting Osteosarcoma heterogeneity to improve therapeutic responsePreprint
Melano, B., Dinh, T., Zirak, B., Woo, B. J., Choi, M. H., Karimzadeh, M., Goodarzi, H., & Sweet-Cordero, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.02.631118
Zhao, T., He, L., Wong, L. P., Mei, S., Xia, J., Xu, Y., Vranken, J. G. V., Mazzola, M. C., Chen, L., Rhee, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650293
Self-citationZhao, T., Qu, P., & Zhao, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114759
Yu, X., Wu, H., Lan, Y., Chen, W., & Liu, J. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101933
Salazar, J., Arranz, M. J., Martín‐Broto, J., Serra, M., Palmerini, E., Martínez, J., Ribelles, A. J., Catalán, M. A., Martínez‐Trufero, J., Gutiérrez, G., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18121855
Zhao, L., Shen, J., Zheng, X., Yuan, Q., & Ye, J. (2025) · Medicine · doi:10.1097/md.0000000000045704
Rajan, S., Franz, E., McAloney, C. A., Vetter, T. A., Cam, M., Gross, A. C., Taslim, C., Wang, M., Cannon, M. V., Oles, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26585433
Rajan, S., Franz, E., McAloney, C. A., Vetter, T. A., Cam, M., Gross, A. C., Taslim, C., Wang, M., Cannon, M. V., Oles, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26585451
Metadata
- Authors
- Sayles, L. C., Breese, M. R., Koehne, A. L., Leung, S. G., Lee, A. G., Liu, H.-Y., Spillinger, A., Shah, A. T., Tanasa, B., Straessler, K., Hazard, F. K., Spunt, S. L., Marina, N., Kim, G. E., Cho, S.-J., Avedian, R. S., Mohler, D. G., Kim, M.-O., DuBois, S. G., Hawkins, D. S., & Sweet-Cordero, E. A.
- Affiliations
- University of California, San Francisco (US)
- 1Division of Hematology and Oncology, Department of Pediatrics, University of California, San Francisco, California.
- Stanford Medicine (US)
- Harvard University (US)
- Seattle Children's Hospital (US)
- ORCID
- Venue
- Cancer Discovery
- Published
- 2019-01-01
- Volume
- 9
- Issue
- 1
- Pages
- 46-63
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC7134333
- OpenAlex
- W2892650455
- Cited by
- 452
- References
- 78
- Citations by year
- 2026: 48 · 2025: 59 · 2024: 67 · 2023: 84 · 2022: 63 · 2021: 63 · 2020: 52 · 2019: 14
- FWCI
- 24.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- HHS | National Institutes of Health (NIH) (S10OD018220, P30CA082103, 2T32OD011121-11, R25 CA180993-02)
- Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels (Hope On Wheels)
- Stanford University School of Medicine (Stanford School of Medicine, Stanford University) (Morgridge Scholar Grant)
- St. Baldrick's Foundation (Team Clarkie)
- CureSearch for Children's Cancer
- Sarcoma Foundation of America (SFA)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- osteosarcoma, somatic copy number alterations, structural rearrangement, targeted therapy, patient-derived xenografts, copy number amplification, gene expression changes, oncogenic drivers
- MeSH terms
- Whole Genome Sequencing, Animals, Bone Neoplasms, Humans, Osteosarcoma, Sequence Analysis, RNA, Xenograft Model Antitumor Assays, Genomics, Mice, Genomic Structural Variation, DNA Copy Number Variations, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
